nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—Pelvic venous thrombosis—Vandetanib—thyroid cancer	0.17	0.22	CcSEcCtD
Estriol—Polyp—Vandetanib—thyroid cancer	0.0168	0.0217	CcSEcCtD
Estriol—Cholelithiasis—Vandetanib—thyroid cancer	0.0165	0.0213	CcSEcCtD
Estriol—Cyst—Vandetanib—thyroid cancer	0.0153	0.0198	CcSEcCtD
Estriol—Embolism venous—Sorafenib—thyroid cancer	0.0137	0.0177	CcSEcCtD
Estriol—ESR2—Nuclear Receptors—THRB—thyroid cancer	0.0133	0.0615	CbGpPWpGaD
Estriol—Cerebral haemorrhage—Sorafenib—thyroid cancer	0.0125	0.0161	CcSEcCtD
Estriol—ESR2—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0105	0.0486	CbGpPWpGaD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.0105	0.0483	CbGpPWpGaD
Estriol—Neoplasm—Vandetanib—thyroid cancer	0.00925	0.012	CcSEcCtD
Estriol—Venous thromboembolism—Epirubicin—thyroid cancer	0.00868	0.0112	CcSEcCtD
Estriol—Venous thromboembolism—Doxorubicin—thyroid cancer	0.00803	0.0104	CcSEcCtD
Estriol—Bone disorder—Sorafenib—thyroid cancer	0.00764	0.00988	CcSEcCtD
Estriol—SLCO1A2—Recycling of bile acids and salts—RXRA—thyroid cancer	0.00705	0.0325	CbGpPWpGaD
Estriol—Blood pressure increased—Sorafenib—thyroid cancer	0.0069	0.00892	CcSEcCtD
Estriol—ESR1—Nuclear Receptors—THRB—thyroid cancer	0.00672	0.031	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.0067	0.0309	CbGpPWpGaD
Estriol—Neoplasm—Sorafenib—thyroid cancer	0.00624	0.00807	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00621	0.0286	CbGpPWpGaD
Estriol—Erythema nodosum—Epirubicin—thyroid cancer	0.0059	0.00762	CcSEcCtD
Estriol—Weight decreased—Vandetanib—thyroid cancer	0.00581	0.00751	CcSEcCtD
Estriol—Infestation NOS—Vandetanib—thyroid cancer	0.00573	0.0074	CcSEcCtD
Estriol—Infestation—Vandetanib—thyroid cancer	0.00573	0.0074	CcSEcCtD
Estriol—Depression—Vandetanib—thyroid cancer	0.00571	0.00738	CcSEcCtD
Estriol—ESR2—Nuclear Receptors—RXRA—thyroid cancer	0.00566	0.0261	CbGpPWpGaD
Estriol—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00553	0.00714	CcSEcCtD
Estriol—Erythema nodosum—Doxorubicin—thyroid cancer	0.00546	0.00705	CcSEcCtD
Estriol—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00541	0.007	CcSEcCtD
Estriol—ESR1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00531	0.0245	CbGpPWpGaD
Estriol—Vaginal moniliasis—Epirubicin—thyroid cancer	0.00506	0.00653	CcSEcCtD
Estriol—Embolism venous—Epirubicin—thyroid cancer	0.00506	0.00653	CcSEcCtD
Estriol—Visual impairment—Vandetanib—thyroid cancer	0.00495	0.0064	CcSEcCtD
Estriol—Erythema multiforme—Vandetanib—thyroid cancer	0.00486	0.00628	CcSEcCtD
Estriol—Vulvovaginal candidiasis—Epirubicin—thyroid cancer	0.00485	0.00627	CcSEcCtD
Estriol—Eye disorder—Vandetanib—thyroid cancer	0.0048	0.00621	CcSEcCtD
Estriol—Cardiac disorder—Vandetanib—thyroid cancer	0.00477	0.00616	CcSEcCtD
Estriol—Vaginal moniliasis—Doxorubicin—thyroid cancer	0.00468	0.00605	CcSEcCtD
Estriol—Embolism venous—Doxorubicin—thyroid cancer	0.00468	0.00605	CcSEcCtD
Estriol—Vulvovaginal mycotic infection—Epirubicin—thyroid cancer	0.00467	0.00603	CcSEcCtD
Estriol—Angiopathy—Vandetanib—thyroid cancer	0.00466	0.00603	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00463	0.0214	CbGpPWpGaD
Estriol—Alopecia—Vandetanib—thyroid cancer	0.00454	0.00587	CcSEcCtD
Estriol—Breast disorder—Sorafenib—thyroid cancer	0.00453	0.00585	CcSEcCtD
Estriol—Mental disorder—Vandetanib—thyroid cancer	0.0045	0.00582	CcSEcCtD
Estriol—Vulvovaginal candidiasis—Doxorubicin—thyroid cancer	0.00449	0.0058	CcSEcCtD
Estriol—ESR2—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00448	0.0206	CbGpPWpGaD
Estriol—Malnutrition—Vandetanib—thyroid cancer	0.00447	0.00578	CcSEcCtD
Estriol—Vulvovaginal mycotic infection—Doxorubicin—thyroid cancer	0.00432	0.00558	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00431	0.0199	CbGpPWpGaD
Estriol—Muscle spasms—Vandetanib—thyroid cancer	0.0043	0.00556	CcSEcCtD
Estriol—Polyp—Epirubicin—thyroid cancer	0.00419	0.00542	CcSEcCtD
Estriol—Abdominal discomfort—Sorafenib—thyroid cancer	0.00415	0.00537	CcSEcCtD
Estriol—SHBG—Nongenotropic Androgen signaling—HRAS—thyroid cancer	0.00399	0.0184	CbGpPWpGaD
Estriol—Weight decreased—Sorafenib—thyroid cancer	0.00392	0.00506	CcSEcCtD
Estriol—Polyp—Doxorubicin—thyroid cancer	0.00388	0.00502	CcSEcCtD
Estriol—Hypertension—Vandetanib—thyroid cancer	0.00386	0.00499	CcSEcCtD
Estriol—Infestation NOS—Sorafenib—thyroid cancer	0.00386	0.00499	CcSEcCtD
Estriol—Infestation—Sorafenib—thyroid cancer	0.00386	0.00499	CcSEcCtD
Estriol—Cyst—Epirubicin—thyroid cancer	0.00382	0.00493	CcSEcCtD
Estriol—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00381	0.00492	CcSEcCtD
Estriol—Anxiety—Vandetanib—thyroid cancer	0.0038	0.00491	CcSEcCtD
Estriol—Myocardial infarction—Sorafenib—thyroid cancer	0.00379	0.00489	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00378	0.00489	CcSEcCtD
Estriol—Seborrhoeic dermatitis—Epirubicin—thyroid cancer	0.00374	0.00484	CcSEcCtD
Estriol—SLCO1A2—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.00369	0.017	CbGpPWpGaD
Estriol—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00365	0.00472	CcSEcCtD
Estriol—Oedema—Vandetanib—thyroid cancer	0.00365	0.00472	CcSEcCtD
Estriol—Infection—Vandetanib—thyroid cancer	0.00363	0.00469	CcSEcCtD
Estriol—Nervous system disorder—Vandetanib—thyroid cancer	0.00358	0.00463	CcSEcCtD
Estriol—ESR2—Nuclear Receptors—PPARG—thyroid cancer	0.00358	0.0165	CbGpPWpGaD
Estriol—Skin disorder—Vandetanib—thyroid cancer	0.00355	0.00458	CcSEcCtD
Estriol—Cyst—Doxorubicin—thyroid cancer	0.00353	0.00456	CcSEcCtD
Estriol—SHBG—Nongenotropic Androgen signaling—AKT1—thyroid cancer	0.00352	0.0162	CbGpPWpGaD
Estriol—Seborrhoeic dermatitis—Doxorubicin—thyroid cancer	0.00346	0.00448	CcSEcCtD
Estriol—Vaginal haemorrhage—Epirubicin—thyroid cancer	0.00345	0.00446	CcSEcCtD
Estriol—Connective tissue disorder—Sorafenib—thyroid cancer	0.00341	0.0044	CcSEcCtD
Estriol—Insomnia—Vandetanib—thyroid cancer	0.0033	0.00427	CcSEcCtD
Estriol—Erythema multiforme—Sorafenib—thyroid cancer	0.00328	0.00424	CcSEcCtD
Estriol—Cardiac disorder—Sorafenib—thyroid cancer	0.00322	0.00416	CcSEcCtD
Estriol—Dyspepsia—Vandetanib—thyroid cancer	0.00321	0.00415	CcSEcCtD
Estriol—Vaginal haemorrhage—Doxorubicin—thyroid cancer	0.00319	0.00412	CcSEcCtD
Estriol—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00315	0.00407	CcSEcCtD
Estriol—Angiopathy—Sorafenib—thyroid cancer	0.00315	0.00407	CcSEcCtD
Estriol—Immune system disorder—Sorafenib—thyroid cancer	0.00313	0.00405	CcSEcCtD
Estriol—Pain—Vandetanib—thyroid cancer	0.00312	0.00404	CcSEcCtD
Estriol—Alopecia—Sorafenib—thyroid cancer	0.00306	0.00396	CcSEcCtD
Estriol—Mental disorder—Sorafenib—thyroid cancer	0.00304	0.00393	CcSEcCtD
Estriol—Malnutrition—Sorafenib—thyroid cancer	0.00302	0.0039	CcSEcCtD
Estriol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00299	0.00386	CcSEcCtD
Estriol—Breast pain—Epirubicin—thyroid cancer	0.00292	0.00378	CcSEcCtD
Estriol—Muscle spasms—Sorafenib—thyroid cancer	0.0029	0.00375	CcSEcCtD
Estriol—Abdominal pain—Vandetanib—thyroid cancer	0.00289	0.00373	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00286	0.0132	CbGpPWpGaD
Estriol—ESR1—Nuclear Receptors—RXRA—thyroid cancer	0.00286	0.0132	CbGpPWpGaD
Estriol—ESR1—FOXM1 transcription factor network—CDK1—thyroid cancer	0.00284	0.0131	CbGpPWpGaD
Estriol—ESR2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00283	0.013	CbGpPWpGaD
Estriol—Bone disorder—Epirubicin—thyroid cancer	0.00282	0.00365	CcSEcCtD
Estriol—Angioedema—Sorafenib—thyroid cancer	0.00276	0.00356	CcSEcCtD
Estriol—Breast pain—Doxorubicin—thyroid cancer	0.00271	0.0035	CcSEcCtD
Estriol—ESR1—Estrogen signaling pathway—BRAF—thyroid cancer	0.00262	0.0121	CbGpPWpGaD
Estriol—Bone disorder—Doxorubicin—thyroid cancer	0.00261	0.00338	CcSEcCtD
Estriol—Hypertension—Sorafenib—thyroid cancer	0.00261	0.00337	CcSEcCtD
Estriol—Pruritus—Vandetanib—thyroid cancer	0.00258	0.00334	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00255	0.0033	CcSEcCtD
Estriol—Vaginal inflammation—Epirubicin—thyroid cancer	0.00255	0.0033	CcSEcCtD
Estriol—Pulmonary embolism—Epirubicin—thyroid cancer	0.00255	0.0033	CcSEcCtD
Estriol—ESR2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00252	0.0116	CbGpPWpGaD
Estriol—Diarrhoea—Vandetanib—thyroid cancer	0.0025	0.00323	CcSEcCtD
Estriol—Anaphylactic shock—Sorafenib—thyroid cancer	0.00246	0.00318	CcSEcCtD
Estriol—Infection—Sorafenib—thyroid cancer	0.00245	0.00316	CcSEcCtD
Estriol—Shock—Sorafenib—thyroid cancer	0.00242	0.00313	CcSEcCtD
Estriol—Fluid retention—Epirubicin—thyroid cancer	0.00242	0.00313	CcSEcCtD
Estriol—ESR1—Nuclear signaling by ERBB4—NRG1—thyroid cancer	0.00242	0.0112	CbGpPWpGaD
Estriol—Nervous system disorder—Sorafenib—thyroid cancer	0.00242	0.00312	CcSEcCtD
Estriol—Dizziness—Vandetanib—thyroid cancer	0.00241	0.00312	CcSEcCtD
Estriol—Vaginal infection—Epirubicin—thyroid cancer	0.00241	0.00311	CcSEcCtD
Estriol—Skin disorder—Sorafenib—thyroid cancer	0.00239	0.00309	CcSEcCtD
Estriol—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00236	0.00305	CcSEcCtD
Estriol—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00236	0.00305	CcSEcCtD
Estriol—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00234	0.00303	CcSEcCtD
Estriol—Vomiting—Vandetanib—thyroid cancer	0.00232	0.003	CcSEcCtD
Estriol—Neoplasm—Epirubicin—thyroid cancer	0.00231	0.00298	CcSEcCtD
Estriol—Rash—Vandetanib—thyroid cancer	0.0023	0.00298	CcSEcCtD
Estriol—Dermatitis—Vandetanib—thyroid cancer	0.0023	0.00297	CcSEcCtD
Estriol—Headache—Vandetanib—thyroid cancer	0.00229	0.00296	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00226	0.0104	CbGpPWpGaD
Estriol—ESR1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00226	0.0104	CbGpPWpGaD
Estriol—Fluid retention—Doxorubicin—thyroid cancer	0.00224	0.0029	CcSEcCtD
Estriol—Vaginal infection—Doxorubicin—thyroid cancer	0.00223	0.00288	CcSEcCtD
Estriol—Abnormal vision—Epirubicin—thyroid cancer	0.00223	0.00288	CcSEcCtD
Estriol—Nausea—Vandetanib—thyroid cancer	0.00217	0.0028	CcSEcCtD
Estriol—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00217	0.0028	CcSEcCtD
Estriol—Dyspepsia—Sorafenib—thyroid cancer	0.00217	0.0028	CcSEcCtD
Estriol—Thrombophlebitis—Epirubicin—thyroid cancer	0.00214	0.00277	CcSEcCtD
Estriol—Neoplasm—Doxorubicin—thyroid cancer	0.00213	0.00276	CcSEcCtD
Estriol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00213	0.00275	CcSEcCtD
Estriol—Pain—Sorafenib—thyroid cancer	0.00211	0.00272	CcSEcCtD
Estriol—Vascular purpura—Epirubicin—thyroid cancer	0.00207	0.00268	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.00206	0.0095	CbGpPWpGaD
Estriol—Abnormal vision—Doxorubicin—thyroid cancer	0.00206	0.00266	CcSEcCtD
Estriol—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00204	0.00264	CcSEcCtD
Estriol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00201	0.0026	CcSEcCtD
Estriol—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00198	0.00256	CcSEcCtD
Estriol—Urticaria—Sorafenib—thyroid cancer	0.00196	0.00253	CcSEcCtD
Estriol—Abdominal pain—Sorafenib—thyroid cancer	0.00195	0.00252	CcSEcCtD
Estriol—Vascular purpura—Doxorubicin—thyroid cancer	0.00192	0.00248	CcSEcCtD
Estriol—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00189	0.00244	CcSEcCtD
Estriol—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00189	0.00244	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—CDK1—thyroid cancer	0.00189	0.0087	CbGpPWpGaD
Estriol—Migraine—Epirubicin—thyroid cancer	0.00182	0.00236	CcSEcCtD
Estriol—ESR2—Generic Transcription Pathway—THRB—thyroid cancer	0.00182	0.00839	CbGpPWpGaD
Estriol—Hypersensitivity—Sorafenib—thyroid cancer	0.00181	0.00235	CcSEcCtD
Estriol—ESR1—Nuclear Receptors—PPARG—thyroid cancer	0.0018	0.00831	CbGpPWpGaD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.00177	0.00817	CbGpPWpGaD
Estriol—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00175	0.00226	CcSEcCtD
Estriol—Pruritus—Sorafenib—thyroid cancer	0.00174	0.00225	CcSEcCtD
Estriol—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00173	0.00799	CbGpPWpGaD
Estriol—Migraine—Doxorubicin—thyroid cancer	0.00169	0.00218	CcSEcCtD
Estriol—Diarrhoea—Sorafenib—thyroid cancer	0.00169	0.00218	CcSEcCtD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.00168	0.00772	CbGpPWpGaD
Estriol—Breast disorder—Epirubicin—thyroid cancer	0.00167	0.00216	CcSEcCtD
Estriol—Dizziness—Sorafenib—thyroid cancer	0.00163	0.00211	CcSEcCtD
Estriol—Abdominal distension—Epirubicin—thyroid cancer	0.00161	0.00208	CcSEcCtD
Estriol—Asthma—Epirubicin—thyroid cancer	0.0016	0.00207	CcSEcCtD
Estriol—Vomiting—Sorafenib—thyroid cancer	0.00157	0.00202	CcSEcCtD
Estriol—ESR2—neck—thyroid cancer	0.00157	0.168	CbGeAlD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00156	0.00718	CbGpPWpGaD
Estriol—Rash—Sorafenib—thyroid cancer	0.00155	0.00201	CcSEcCtD
Estriol—Dermatitis—Sorafenib—thyroid cancer	0.00155	0.00201	CcSEcCtD
Estriol—Breast disorder—Doxorubicin—thyroid cancer	0.00155	0.002	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.00154	0.00712	CbGpPWpGaD
Estriol—Headache—Sorafenib—thyroid cancer	0.00154	0.00199	CcSEcCtD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.00154	0.00709	CbGpPWpGaD
Estriol—SHBG—neck—thyroid cancer	0.00152	0.163	CbGeAlD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—thyroid cancer	0.00152	0.00698	CbGpPWpGaD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.00151	0.00695	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.00151	0.00694	CbGpPWpGaD
Estriol—Abdominal distension—Doxorubicin—thyroid cancer	0.00149	0.00193	CcSEcCtD
Estriol—Asthma—Doxorubicin—thyroid cancer	0.00148	0.00191	CcSEcCtD
Estriol—Nausea—Sorafenib—thyroid cancer	0.00146	0.00189	CcSEcCtD
Estriol—Weight increased—Epirubicin—thyroid cancer	0.00146	0.00188	CcSEcCtD
Estriol—Weight decreased—Epirubicin—thyroid cancer	0.00145	0.00187	CcSEcCtD
Estriol—Infestation—Epirubicin—thyroid cancer	0.00143	0.00184	CcSEcCtD
Estriol—Infestation NOS—Epirubicin—thyroid cancer	0.00143	0.00184	CcSEcCtD
Estriol—ESR1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00143	0.00657	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—TERT—thyroid cancer	0.00139	0.00642	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00136	0.00627	CbGpPWpGaD
Estriol—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00135	0.00174	CcSEcCtD
Estriol—Weight increased—Doxorubicin—thyroid cancer	0.00135	0.00174	CcSEcCtD
Estriol—Weight decreased—Doxorubicin—thyroid cancer	0.00134	0.00173	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.00133	0.00613	CbGpPWpGaD
Estriol—Infestation—Doxorubicin—thyroid cancer	0.00132	0.00171	CcSEcCtD
Estriol—Infestation NOS—Doxorubicin—thyroid cancer	0.00132	0.00171	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.0013	0.006	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00127	0.00585	CbGpPWpGaD
Estriol—Oedema peripheral—Epirubicin—thyroid cancer	0.00126	0.00163	CcSEcCtD
Estriol—Connective tissue disorder—Epirubicin—thyroid cancer	0.00126	0.00163	CcSEcCtD
Estriol—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00125	0.00161	CcSEcCtD
Estriol—Visual impairment—Epirubicin—thyroid cancer	0.00123	0.0016	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.00122	0.00561	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.00121	0.00559	CbGpPWpGaD
Estriol—ESR2—Gene Expression—TRIM33—thyroid cancer	0.00121	0.00559	CbGpPWpGaD
Estriol—Erythema multiforme—Epirubicin—thyroid cancer	0.00121	0.00157	CcSEcCtD
Estriol—SLCO1A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00121	0.00556	CbGpPWpGaD
Estriol—SLCO1A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00121	0.00556	CbGpPWpGaD
Estriol—Eye disorder—Epirubicin—thyroid cancer	0.0012	0.00155	CcSEcCtD
Estriol—Cardiac disorder—Epirubicin—thyroid cancer	0.00119	0.00154	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—CCND1—thyroid cancer	0.00118	0.00545	CbGpPWpGaD
Estriol—Oedema peripheral—Doxorubicin—thyroid cancer	0.00117	0.00151	CcSEcCtD
Estriol—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00116	0.00151	CcSEcCtD
Estriol—Angiopathy—Epirubicin—thyroid cancer	0.00116	0.0015	CcSEcCtD
Estriol—Immune system disorder—Epirubicin—thyroid cancer	0.00116	0.0015	CcSEcCtD
Estriol—ESR2—Generic Transcription Pathway—MEN1—thyroid cancer	0.00116	0.00533	CbGpPWpGaD
Estriol—Visual impairment—Doxorubicin—thyroid cancer	0.00114	0.00148	CcSEcCtD
Estriol—Alopecia—Epirubicin—thyroid cancer	0.00113	0.00146	CcSEcCtD
Estriol—Mental disorder—Epirubicin—thyroid cancer	0.00112	0.00145	CcSEcCtD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00112	0.00517	CbGpPWpGaD
Estriol—Erythema multiforme—Doxorubicin—thyroid cancer	0.00112	0.00145	CcSEcCtD
Estriol—Malnutrition—Epirubicin—thyroid cancer	0.00112	0.00144	CcSEcCtD
Estriol—Eye disorder—Doxorubicin—thyroid cancer	0.00111	0.00143	CcSEcCtD
Estriol—Cardiac disorder—Doxorubicin—thyroid cancer	0.0011	0.00142	CcSEcCtD
Estriol—Flatulence—Epirubicin—thyroid cancer	0.0011	0.00142	CcSEcCtD
Estriol—Tension—Epirubicin—thyroid cancer	0.00109	0.00141	CcSEcCtD
Estriol—Nervousness—Epirubicin—thyroid cancer	0.00108	0.0014	CcSEcCtD
Estriol—Back pain—Epirubicin—thyroid cancer	0.00108	0.00139	CcSEcCtD
Estriol—Angiopathy—Doxorubicin—thyroid cancer	0.00108	0.00139	CcSEcCtD
Estriol—ESR1—neck—thyroid cancer	0.00107	0.115	CbGeAlD
Estriol—Muscle spasms—Epirubicin—thyroid cancer	0.00107	0.00139	CcSEcCtD
Estriol—Immune system disorder—Doxorubicin—thyroid cancer	0.00107	0.00138	CcSEcCtD
Estriol—ESR1—Estrogen signaling pathway—AKT1—thyroid cancer	0.00107	0.00491	CbGpPWpGaD
Estriol—Alopecia—Doxorubicin—thyroid cancer	0.00105	0.00135	CcSEcCtD
Estriol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00104	0.00481	CbGpPWpGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.00104	0.00479	CbGpPWpGaD
Estriol—Mental disorder—Doxorubicin—thyroid cancer	0.00104	0.00134	CcSEcCtD
Estriol—Malnutrition—Doxorubicin—thyroid cancer	0.00103	0.00133	CcSEcCtD
Estriol—Flatulence—Doxorubicin—thyroid cancer	0.00102	0.00131	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—CDK1—thyroid cancer	0.00102	0.00468	CbGpPWpGaD
Estriol—Tension—Doxorubicin—thyroid cancer	0.00101	0.00131	CcSEcCtD
Estriol—Nervousness—Doxorubicin—thyroid cancer	0.001	0.0013	CcSEcCtD
Estriol—Back pain—Doxorubicin—thyroid cancer	0.000998	0.00129	CcSEcCtD
Estriol—Muscle spasms—Doxorubicin—thyroid cancer	0.000992	0.00128	CcSEcCtD
Estriol—Hypertension—Epirubicin—thyroid cancer	0.000963	0.00124	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000947	0.00437	CbGpPWpGaD
Estriol—Anxiety—Epirubicin—thyroid cancer	0.000946	0.00122	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000943	0.00122	CcSEcCtD
Estriol—ESR1—Generic Transcription Pathway—THRB—thyroid cancer	0.000918	0.00423	CbGpPWpGaD
Estriol—Anaphylactic shock—Epirubicin—thyroid cancer	0.00091	0.00118	CcSEcCtD
Estriol—Oedema—Epirubicin—thyroid cancer	0.00091	0.00118	CcSEcCtD
Estriol—Infection—Epirubicin—thyroid cancer	0.000904	0.00117	CcSEcCtD
Estriol—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000902	0.00416	CbGpPWpGaD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000902	0.00416	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—CCND1—thyroid cancer	0.000902	0.00416	CbGpPWpGaD
Estriol—Shock—Epirubicin—thyroid cancer	0.000896	0.00116	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.000894	0.00412	CbGpPWpGaD
Estriol—Nervous system disorder—Epirubicin—thyroid cancer	0.000893	0.00115	CcSEcCtD
Estriol—Hypertension—Doxorubicin—thyroid cancer	0.000891	0.00115	CcSEcCtD
Estriol—Skin disorder—Epirubicin—thyroid cancer	0.000884	0.00114	CcSEcCtD
Estriol—ESR2—Gene Expression—THRB—thyroid cancer	0.000876	0.00404	CbGpPWpGaD
Estriol—Anxiety—Doxorubicin—thyroid cancer	0.000876	0.00113	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000873	0.00113	CcSEcCtD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000845	0.00389	CbGpPWpGaD
Estriol—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000842	0.00109	CcSEcCtD
Estriol—Oedema—Doxorubicin—thyroid cancer	0.000842	0.00109	CcSEcCtD
Estriol—Infection—Doxorubicin—thyroid cancer	0.000837	0.00108	CcSEcCtD
Estriol—Shock—Doxorubicin—thyroid cancer	0.000829	0.00107	CcSEcCtD
Estriol—Nervous system disorder—Doxorubicin—thyroid cancer	0.000826	0.00107	CcSEcCtD
Estriol—Insomnia—Epirubicin—thyroid cancer	0.000823	0.00106	CcSEcCtD
Estriol—Skin disorder—Doxorubicin—thyroid cancer	0.000818	0.00106	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000815	0.00376	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—NRG1—thyroid cancer	0.000815	0.00376	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—CCND1—thyroid cancer	0.000805	0.00371	CbGpPWpGaD
Estriol—Dyspepsia—Epirubicin—thyroid cancer	0.000801	0.00104	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000786	0.00362	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000786	0.00102	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000785	0.00362	CbGpPWpGaD
Estriol—Pain—Epirubicin—thyroid cancer	0.000778	0.00101	CcSEcCtD
Estriol—SLCO1A2—Metabolism—MINPP1—thyroid cancer	0.000775	0.00357	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—RXRA—thyroid cancer	0.000773	0.00356	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000773	0.00356	CbGpPWpGaD
Estriol—ESR1—LKB1 signaling events—TP53—thyroid cancer	0.000765	0.00353	CbGpPWpGaD
Estriol—Insomnia—Doxorubicin—thyroid cancer	0.000762	0.000985	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.00076	0.0035	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000759	0.0035	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000755	0.00348	CbGpPWpGaD
Estriol—ESR2—thyroid gland—thyroid cancer	0.000745	0.0799	CbGeAlD
Estriol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000744	0.000962	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—CCND1—thyroid cancer	0.000744	0.00343	CbGpPWpGaD
Estriol—Dyspepsia—Doxorubicin—thyroid cancer	0.000741	0.000958	CcSEcCtD
Estriol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000727	0.00094	CcSEcCtD
Estriol—SHBG—thyroid gland—thyroid cancer	0.000724	0.0776	CbGeAlD
Estriol—Urticaria—Epirubicin—thyroid cancer	0.000723	0.000935	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000722	0.00333	CbGpPWpGaD
Estriol—Pain—Doxorubicin—thyroid cancer	0.00072	0.000931	CcSEcCtD
Estriol—Abdominal pain—Epirubicin—thyroid cancer	0.00072	0.00093	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000699	0.00322	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000693	0.0032	CbGpPWpGaD
Estriol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000689	0.00089	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000674	0.00311	CbGpPWpGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.000671	0.00309	CbGpPWpGaD
Estriol—Hypersensitivity—Epirubicin—thyroid cancer	0.000671	0.000867	CcSEcCtD
Estriol—Urticaria—Doxorubicin—thyroid cancer	0.000669	0.000865	CcSEcCtD
Estriol—Abdominal pain—Doxorubicin—thyroid cancer	0.000666	0.000861	CcSEcCtD
Estriol—ESR2—head—thyroid cancer	0.000661	0.0709	CbGeAlD
Estriol—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	0.000659	0.00304	CbGpPWpGaD
Estriol—Pruritus—Epirubicin—thyroid cancer	0.000644	0.000832	CcSEcCtD
Estriol—Diarrhoea—Epirubicin—thyroid cancer	0.000623	0.000805	CcSEcCtD
Estriol—Hypersensitivity—Doxorubicin—thyroid cancer	0.000621	0.000802	CcSEcCtD
Estriol—SLCO1A2—Metabolism—CHST14—thyroid cancer	0.00062	0.00286	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000612	0.00282	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000612	0.00282	CbGpPWpGaD
Estriol—ESR1—Gene Expression—TRIM33—thyroid cancer	0.000611	0.00282	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000602	0.00278	CbGpPWpGaD
Estriol—Dizziness—Epirubicin—thyroid cancer	0.000602	0.000778	CcSEcCtD
Estriol—Pruritus—Doxorubicin—thyroid cancer	0.000596	0.00077	CcSEcCtD
Estriol—ESR2—Gene Expression—TPR—thyroid cancer	0.000592	0.00273	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000583	0.00269	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000582	0.00269	CbGpPWpGaD
Estriol—Vomiting—Epirubicin—thyroid cancer	0.000579	0.000748	CcSEcCtD
Estriol—Diarrhoea—Doxorubicin—thyroid cancer	0.000576	0.000745	CcSEcCtD
Estriol—Rash—Epirubicin—thyroid cancer	0.000574	0.000742	CcSEcCtD
Estriol—Dermatitis—Epirubicin—thyroid cancer	0.000573	0.000741	CcSEcCtD
Estriol—Headache—Epirubicin—thyroid cancer	0.00057	0.000737	CcSEcCtD
Estriol—Dizziness—Doxorubicin—thyroid cancer	0.000557	0.00072	CcSEcCtD
Estriol—ESR2—Gene Expression—MEN1—thyroid cancer	0.000557	0.00257	CbGpPWpGaD
Estriol—Nausea—Epirubicin—thyroid cancer	0.000541	0.000699	CcSEcCtD
Estriol—Vomiting—Doxorubicin—thyroid cancer	0.000536	0.000692	CcSEcCtD
Estriol—SLCO1A2—head—thyroid cancer	0.000534	0.0572	CbGeAlD
Estriol—Rash—Doxorubicin—thyroid cancer	0.000531	0.000686	CcSEcCtD
Estriol—Dermatitis—Doxorubicin—thyroid cancer	0.000531	0.000686	CcSEcCtD
Estriol—Headache—Doxorubicin—thyroid cancer	0.000528	0.000682	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—TP53—thyroid cancer	0.000518	0.00239	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000518	0.00239	CbGpPWpGaD
Estriol—ESR1—thyroid gland—thyroid cancer	0.00051	0.0547	CbGeAlD
Estriol—Nausea—Doxorubicin—thyroid cancer	0.0005	0.000647	CcSEcCtD
Estriol—SLCO1A2—Metabolism—HPGD—thyroid cancer	0.000499	0.0023	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—PPARG—thyroid cancer	0.000488	0.00225	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—HRAS—thyroid cancer	0.000469	0.00216	CbGpPWpGaD
Estriol—ESR2—lymph node—thyroid cancer	0.000463	0.0496	CbGeAlD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.00046	0.00212	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000458	0.00211	CbGpPWpGaD
Estriol—ESR1—head—thyroid cancer	0.000453	0.0485	CbGeAlD
Estriol—ESR1—Regulation of Telomerase—AKT1—thyroid cancer	0.000448	0.00206	CbGpPWpGaD
Estriol—ESR1—Gene Expression—THRB—thyroid cancer	0.000442	0.00204	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000425	0.00196	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CALCB—thyroid cancer	0.000419	0.00193	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000415	0.00191	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—AKT1—thyroid cancer	0.000414	0.00191	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.00041	0.00189	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—PTEN—thyroid cancer	0.000408	0.00188	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000405	0.00187	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TRIM33—thyroid cancer	0.000397	0.00183	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—RXRA—thyroid cancer	0.00039	0.0018	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.00039	0.0018	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000389	0.00179	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000389	0.00179	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000385	0.00178	CbGpPWpGaD
Estriol—ESR2—Gene Expression—RXRA—thyroid cancer	0.000372	0.00172	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—NRAS—thyroid cancer	0.000364	0.00168	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000352	0.00162	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.00034	0.00157	CbGpPWpGaD
Estriol—ABCB1—Metabolism—MINPP1—thyroid cancer	0.000332	0.00153	CbGpPWpGaD
Estriol—ESR1—lymph node—thyroid cancer	0.000317	0.034	CbGeAlD
Estriol—ESR1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000315	0.00145	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—KRAS—thyroid cancer	0.000313	0.00144	CbGpPWpGaD
Estriol—ESR1—Gene Expression—TPR—thyroid cancer	0.000298	0.00138	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—TPR—thyroid cancer	0.000287	0.00132	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	0.000282	0.0013	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NDUFA13—thyroid cancer	0.000282	0.0013	CbGpPWpGaD
Estriol—ESR1—Gene Expression—MEN1—thyroid cancer	0.000281	0.00129	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.00028	0.00129	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—HRAS—thyroid cancer	0.000266	0.00123	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CHST14—thyroid cancer	0.000265	0.00122	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TCF7L1—thyroid cancer	0.000265	0.00122	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000262	0.00121	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000262	0.00121	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000261	0.0012	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000258	0.00119	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000256	0.00118	CbGpPWpGaD
Estriol—ABCB1—trachea—thyroid cancer	0.000255	0.0273	CbGeAlD
Estriol—ESR1—Generic Transcription Pathway—PPARG—thyroid cancer	0.000246	0.00113	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000243	0.00112	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000236	0.00109	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—AKT1—thyroid cancer	0.000235	0.00108	CbGpPWpGaD
Estriol—ESR2—Gene Expression—PPARG—thyroid cancer	0.000235	0.00108	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000232	0.00107	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	0.000215	0.00099	CbGpPWpGaD
Estriol—ABCB1—Metabolism—HPGD—thyroid cancer	0.000214	0.000986	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000206	0.000951	CbGpPWpGaD
Estriol—ABCB1—thyroid gland—thyroid cancer	0.000202	0.0216	CbGeAlD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000201	0.000928	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000196	0.000905	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000196	0.000903	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TSHR—thyroid cancer	0.000194	0.000895	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000191	0.00088	CbGpPWpGaD
Estriol—ESR1—Gene Expression—RXRA—thyroid cancer	0.000188	0.000865	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000186	0.000859	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MEN1—thyroid cancer	0.000182	0.000841	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—RXRA—thyroid cancer	0.00018	0.000832	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.00018	0.000829	CbGpPWpGaD
Estriol—ABCB1—head—thyroid cancer	0.000179	0.0192	CbGeAlD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000175	0.000809	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PTCH1—thyroid cancer	0.000165	0.000761	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000165	0.00076	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—SST—thyroid cancer	0.000151	0.000696	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CALCA—thyroid cancer	0.000145	0.00067	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000138	0.000637	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CDK1—thyroid cancer	0.000131	0.000606	CbGpPWpGaD
Estriol—ABCB1—lymph node—thyroid cancer	0.000125	0.0134	CbGeAlD
Estriol—ABCB1—Metabolism—TPR—thyroid cancer	0.000123	0.000566	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000123	0.000566	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PRKAR1A—thyroid cancer	0.000121	0.000557	CbGpPWpGaD
Estriol—ESR1—Gene Expression—PPARG—thyroid cancer	0.000119	0.000546	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PPARG—thyroid cancer	0.000114	0.000525	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NRG1—thyroid cancer	0.000106	0.000487	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000104	0.000478	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TERT—thyroid cancer	9.48e-05	0.000437	CbGpPWpGaD
Estriol—ESR2—Gene Expression—AKT1—thyroid cancer	9.29e-05	0.000428	CbGpPWpGaD
Estriol—ABCB1—Metabolism—SLC5A5—thyroid cancer	9.19e-05	0.000424	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—HIF1A—thyroid cancer	9.06e-05	0.000418	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PTGS2—thyroid cancer	8.96e-05	0.000413	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PTEN—thyroid cancer	7.81e-05	0.00036	CbGpPWpGaD
Estriol—ABCB1—Metabolism—RXRA—thyroid cancer	7.72e-05	0.000356	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—BRAF—thyroid cancer	7.51e-05	0.000346	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CCND1—thyroid cancer	5.48e-05	0.000253	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PTEN—thyroid cancer	5.29e-05	0.000244	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PPARG—thyroid cancer	4.88e-05	0.000225	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NRAS—thyroid cancer	4.72e-05	0.000217	CbGpPWpGaD
Estriol—ESR1—Gene Expression—AKT1—thyroid cancer	4.69e-05	0.000216	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—AKT1—thyroid cancer	4.5e-05	0.000208	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KRAS—thyroid cancer	4.06e-05	0.000187	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PTGS2—thyroid cancer	3.84e-05	0.000177	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TP53—thyroid cancer	3.61e-05	0.000166	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—HRAS—thyroid cancer	3.45e-05	0.000159	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PTEN—thyroid cancer	3.35e-05	0.000154	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AKT1—thyroid cancer	3.05e-05	0.00014	CbGpPWpGaD
Estriol—ABCB1—Metabolism—AKT1—thyroid cancer	1.93e-05	8.89e-05	CbGpPWpGaD
